Our data suggest that in the majority of RCC tumours in which VHL has a truncating mutation, even if the PTC is located before the 50–54 nt boundary, mutant mRNA is present, albeit at a reduced level in some tumours. The gene discussed is VHL; the disease is renal cell carcinoma.